|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM351483942 |
| 003 |
DE-627 |
| 005 |
20231226051456.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202210047
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1171.xml
|
| 035 |
|
|
|a (DE-627)NLM351483942
|
| 035 |
|
|
|a (NLM)36637449
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Dou, Yunsheng
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Orally Administrable H2 S-Scavenging Metal-Organic Framework Prepared by Co-Flow Microfluidics for Comprehensive Restoration of Intestinal Milieu
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 07.04.2023
|
| 500 |
|
|
|a Date Revised 07.04.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Intestinal milieu disorders are strongly related to the occurrence of inflammatory bowel diseases (IBDs), which results from mucosa destruction, epithelium disruption, and tight junction (TJ) proteins loss. Excess of H2 S in the intestinal milieu produced by the sulfate-reducing bacteria metabolism contributes to development of IBDs via epithelial barrier breakdown. Conventional interventions, such as surgery and anti-inflammatory medications, are considered not completely effective because of frequent recurrence and other complications. Herein, a novel oral delivery system, a hydroxypropyl methylcellulose acetate succinate (HPMCAS)-based polymer-coated Zr-based metal-organic framework (UiO-66) with a Cux -rhodamine B (CR) probe (hereinafter referred to as HUR), is produced via a co-flow microfluidic approach with the ability to reduce H2 S levels, thus restoring the intestinal lumen milieu. HPMCAS serves as an enteric coating that exposes UiO-66CR at the pH of the intestine but not the acidic pH of the stomach. The synthesized HUR exhibits notable therapeutic efficacy, including mucosa recovery, epithelium integrity restoration, and TJ proteins upregulation via H2 S scavenging to protect against intestinal barrier damage and microbiome dysbiosis. Thus, HUR is verified to be a promising theranostic platform able to decrease the H2 S content for intestinal milieu disorder treatment. The presented study therefore opens the door for further exploitation for IBDs therapy
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Zr metal-organic frameworks
|
| 650 |
|
4 |
|a hydrogen sulfide scavenging
|
| 650 |
|
4 |
|a inflammatory bowel disease
|
| 650 |
|
4 |
|a intestinal milieu restoration
|
| 650 |
|
4 |
|a microfluidic technology
|
| 650 |
|
7 |
|a Metal-Organic Frameworks
|2 NLM
|
| 650 |
|
7 |
|a UiO-66
|2 NLM
|
| 650 |
|
7 |
|a Hydrogen Sulfide
|2 NLM
|
| 650 |
|
7 |
|a YY9FVM7NSN
|2 NLM
|
| 700 |
1 |
|
|a Liu, Ping
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ding, Ziqiao
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhou, Yue
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jing, Huaqing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ren, Yingzi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Heger, Zbynek
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Adam, Vojtech
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Nan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 35(2023), 14 vom: 01. Apr., Seite e2210047
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:35
|g year:2023
|g number:14
|g day:01
|g month:04
|g pages:e2210047
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202210047
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 35
|j 2023
|e 14
|b 01
|c 04
|h e2210047
|